Sodium iodide i-123 - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for sodium iodide i-123 and what is the scope of freedom to operate?

Sodium iodide i-123 is the generic ingredient in one branded drug marketed by Cardinal Health 418, Curium, and Ge Healthcare, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sodium iodide i-123. Two suppliers are listed for this compound.

Summary for sodium iodide i-123

US Patents:	0
Tradenames:	1
Applicants:	3
NDAs:	4
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	18
Patent Applications:	10
DailyMed Link:	sodium iodide i-123 at DailyMed

Recent Clinical Trials for sodium iodide i-123

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University Health Network, Toronto	Phase 4
Stryker Endoscopy	Phase 4
Osaka University	Phase 1

See all sodium iodide i-123 clinical trials

US Patents and Regulatory Information for sodium iodide i-123

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Curium	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	071909-001	Feb 28, 1989	AA	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ge Healthcare	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	017630-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cardinal Health 418	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	018671-002	May 27, 1982	AA	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.